NSE - Delayed Quote INR

Acutaas Chemicals Limited (ACUTAAS.NS)

3,882.60 -44.30 (-1.13%)

At close: November 9 at 3:29:59 PM GMT+5:30

Chart Range Bar

Loading chart for ACUTAAS.NS

Previous Close 3,926.90
Open 3,901.00
Bid --
Ask --
Day's Range 3,782.50 - 3,955.00
52 Week Range 1,570.00 - 4,045.30
Volume 441,369
Avg. Volume 491,226
Market Cap (intraday) 317.873B
Beta (5Y Monthly) -0.11
PE Ratio (TTM) 71.86
EPS (TTM) 54.03
Earnings Date --
Forward Dividend & Yield 2.50 (0.06%)
1y Target Est 3,744.11
Moby Rating Neutral

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients, as well as new chemical entities. It also provides specialty chemicals, including photoresist chemicals for semiconductor applications; electrolyte additives for lithium battery cells; and parabens, methyl salicylate, and other commodity chemicals for cosmetics, agrochemicals, and fine chemicals. The company was formerly known as Ami Organics Limited and changed its name to Acutaas Chemicals Limited in May 2025. Acutaas Chemicals Limited was founded in 2004 and is based in Surat, India.

www.acutaas.com

1,007

Full Time Employees

March 31

Fiscal Year Ends

Basic Materials

Sector

Specialty Chemicals

Industry

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ACUTAAS.NS

127.90%

S&P BSE SENSEX (^BSESN)

4.83%

1-Year Return

ACUTAAS.NS

120.14%

S&P BSE SENSEX (^BSESN)

2.54%

3-Year Return

ACUTAAS.NS

605.04%

S&P BSE SENSEX (^BSESN)

25.10%

5-Year Return

ACUTAAS.NS

648.30%

S&P BSE SENSEX (^BSESN)

34.21%

Earnings Per Share

gaap GAAP

nongaap Normalized

gaap GAAP

nongaap Normalized

Revenue vs. Earnings

yearly Annual

quarterly Quarterly

yearly Annual

quarterly Quarterly

Q2 FY27

Revenue 4.37B

Earnings 1.25B

Profit Margin 28.65%

FY26

FY27

24.0%

26.0%

28.0%

30.0%

Analyst Price Targets

1,783.00 Low

3,744.11 Average

3,882.60 Current

4,851.00 High

Analyst Recommendations

Strong Buy
Buy
Hold
Underperform
Sell

Valuation Measures

  
  
 Annual 

Market Cap
Enterprise Value
Trailing P/E
Forward P/E
PEG Ratio (current)
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue
Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

Profit Margin

27.58%
Return on Assets (ttm)

18.57%
Return on Equity (ttm)

26.11%
Revenue (ttm)

15.93B
Net Income Avi to Common (ttm)

4.39B
Diluted EPS (ttm)

54.03

Balance Sheet and Cash Flow

Total Cash (mrq)

3.07B
Total Debt/Equity (mrq)

0.79%
Levered Free Cash Flow (ttm)

-260.59M

CLEAN.NS Clean Science and Technology Limited

695.95 +1.76%

SANSERA.NS Sansera Engineering Limited

4,653.40 +5.42%

MTARTECH.NS MTAR Technologies Limited

5,516.50 -3.57%

ANURAS.NS Anupam Rasayan India Ltd

1,198.30 +1.05%

TATVA.NS Tatva Chintan Pharma Chem Limited

1,668.30 +2.70%

U.S. markets open in 8h 10m

Acutaas Chemicals Limited (ACUTAAS.NS)

-0.26%

22.84%

42.00%

127.73%

119.98%

641.56%

753.32%

Acutaas Chemicals Limited Overview Specialty Chemicals / Basic Materials

Full Time Employees

Fiscal Year Ends

Sector

Industry

Recent News

Performance Overview

YTD Return

1-Year Return

3-Year Return

5-Year Return

Earnings Trends

Earnings Per Share

Revenue vs. Earnings

Analyst Insights

Analyst Price Targets

Analyst Recommendations

Statistics

Valuation Measures

Financial Highlights

Profitability and Income Statement

Balance Sheet and Cash Flow

Company Insights

Research Reports

People Also Watch